OraSure Technologies Inc Overview
Industry: Medical Instruments & Supplies
Sector: Healthcare
Read MoreMavefund brings filings, fundamentals, valuation, price history and news for OraSure Technologies Inc into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $27.9M (reported); EPS was $69 (reported).
Revenue
$27.9M
reported
EPS
$69
reported
Net loss
-$0M
reported
Cash
$177M
reported
What changed
- Revenue reported to $27.9M; EPS reported to $69.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Earnings release
Open filing
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
SEC filing
10-Q
May 08, 2026
SEC filing
8-K
May 06, 2026
SEC filing
10-K
Mar 09, 2026
Earnings release
Earnings release
Feb 25, 2026
SEC filing
8-K
Feb 25, 2026
SEC filing
8-K
Nov 05, 2025
SEC filing
10-Q
Nov 05, 2025
Earnings release
Earnings release
Nov 05, 2025
SEC filing
10-Q
Aug 06, 2025
SEC filing
8-K
Aug 05, 2025
Earnings release
Earnings release
Aug 05, 2025
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
Headline from GlobeNewswire: OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th.
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
Headline from Yahoo Finance Singapore: OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th.
OraSure wins FDA emergency nod for Ebola test (OSUR:NASDAQ)
Headline from Seeking Alpha: OraSure wins FDA emergency nod for Ebola test (OSUR:NASDAQ).
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
Headline from GlobeNewswire: OraSure Receives Emergency Use Authorization for Second Generation Ebola Test.
Earnings Per Share
Score 2.00/5
OraSure Technologies Inc earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
In
Medical Instruments & Supplies industry
, West Pharmaceutical Services Inc
, Hologic Inc
, Haemonetics
are companies with high ratings.
Return on Equity
Score 3.16/5
OraSure Technologies Inc stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Score 1.23/5
OraSure Technologies Inc
olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Score 3.65/5
OraSure Technologies Inc
attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
, also exhibit high scores.
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Verified SEC statements load when this section enters view.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.
Financial Ratio
Yearly
Quarterly
Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios